Optinose Stock Analysis
| OPTN Stock | USD 0.54 0.04 8.00% |
OptiNose is undervalued with Real Value of 1.14 and Target Price of 3.0. The main objective of OptiNose stock analysis is to determine its intrinsic value, which is an estimate of what OptiNose is worth, separate from its market price. There are two main types of OptiNose's stock analysis: fundamental analysis and technical analysis.
The OptiNose stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. OptiNose is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. OptiNose Stock trading window is adjusted to America/New York timezone.
OptiNose |
OptiNose Stock Analysis Notes
About 78.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.29. OptiNose had not issued any dividends in recent years. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people. To find out more about OptiNose contact Peter Miller at 267 364 3500 or learn more at https://www.optinose.com.OptiNose Investment Alerts
| OptiNose generated a negative expected return over the last 90 days | |
| OptiNose has high historical volatility and very poor performance | |
| OptiNose has some characteristics of a very speculative penny stock | |
| OptiNose has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 70.99 M. Net Loss for the year was (35.48 M) with profit before overhead, payroll, taxes, and interest of 67.01 M. | |
| OptiNose currently holds about 78.26 M in cash with (20.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| OptiNose has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference |
OptiNose Upcoming and Recent Events
Earnings reports are used by OptiNose to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
OptiNose Largest EPS Surprises
Earnings surprises can significantly impact OptiNose's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2024-08-08 | 2024-06-30 | -0.08 | -0.05 | 0.03 | 37 | ||
2023-05-11 | 2023-03-31 | -0.14 | -0.17 | -0.03 | 21 |
OptiNose Stock Institutional Investors
| Shares | Massachusetts Financial Services Company | 2024-09-30 | 3.1 M | Easterly Investment Partners. | 2024-09-30 | 2.4 M | Velan Capital Investment Management Lp | 2024-09-30 | 2.1 M | Geode Capital Management, Llc | 2024-09-30 | 1.3 M | Prescott Group Capital Management Llc | 2024-09-30 | 1.3 M | Rice Hall James & Associates, Llc | 2024-09-30 | 1.1 M | Gmt Capital Corp | 2024-09-30 | 1.1 M | J. Goldman & Co Lp | 2024-09-30 | 675 K | Millennium Management Llc | 2024-09-30 | 629.1 K | Fmr Inc | 2024-09-30 | 16.5 M | Mvm Partners Llc | 2024-09-30 | 14.6 M |
OptiNose Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.92 M.OptiNose Profitablity
The company has Profit Margin (PM) of (0.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | 0.33 | 0.35 | |
| Return On Assets | (0.33) | (0.35) | |
| Return On Equity | 0.41 | 0.43 |
Management Efficiency
OptiNose has return on total asset (ROA) of (0.1032) % which means that it has lost $0.1032 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.505) %, meaning that it created substantial loss on money invested by shareholders. OptiNose's management efficiency ratios could be used to measure how well OptiNose manages its routine affairs as well as how well it operates its assets and liabilities. At this time, OptiNose's Return On Capital Employed is very stable compared to the past year. As of the 3rd of December 2024, Return On Equity is likely to grow to 0.43, while Return On Tangible Assets are likely to drop (0.35). At this time, OptiNose's Total Assets are very stable compared to the past year. As of the 3rd of December 2024, Other Current Assets is likely to grow to about 4.2 M, though Net Tangible Assets are likely to grow to (61.9 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.77) | (0.73) | |
| Tangible Book Value Per Share | (0.77) | (0.73) | |
| Enterprise Value Over EBITDA | (13.03) | (12.38) | |
| Price Book Value Ratio | (1.67) | (1.75) | |
| Enterprise Value Multiple | (13.03) | (12.38) | |
| Price Fair Value | (1.67) | (1.75) | |
| Enterprise Value | 202.6 M | 133.5 M |
Understanding the operational decisions made by OptiNose management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin (0.10) | Profit Margin (0.41) | Beta (0.07) | Return On Assets (0.10) | Return On Equity (10.51) |
Technical Drivers
As of the 3rd of December, OptiNose holds the Variance of 39.12, coefficient of variation of (749.93), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OptiNose, as well as the relationship between them.OptiNose Price Movement Analysis
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OptiNose middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OptiNose. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
OptiNose Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OptiNose insiders, such as employees or executives, is commonly permitted as long as it does not rely on OptiNose's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OptiNose insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
OptiNose Outstanding Bonds
OptiNose issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OptiNose uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OptiNose bonds can be classified according to their maturity, which is the date when OptiNose has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US68404LAA08 Corp BondUS68404LAA08 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
OptiNose Predictive Daily Indicators
OptiNose intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OptiNose stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OptiNose Forecast Models
OptiNose's time-series forecasting models are one of many OptiNose's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OptiNose's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About OptiNose Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OptiNose prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OptiNose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OptiNose. By using and applying OptiNose Stock analysis, traders can create a robust methodology for identifying OptiNose entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.50) | (0.52) | |
| Operating Profit Margin | (0.32) | (0.34) | |
| Net Loss | (0.50) | (0.52) | |
| Gross Profit Margin | 0.88 | 0.68 |
Current OptiNose Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. OptiNose analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. OptiNose analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 3.0 | Strong Buy | 4 | Odds |
Most OptiNose analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand OptiNose stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of OptiNose, talking to its executives and customers, or listening to OptiNose conference calls.
OptiNose Stock Analysis Indicators
OptiNose stock analysis indicators help investors evaluate how OptiNose stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading OptiNose shares will generate the highest return on investment. By understating and applying OptiNose stock analysis, traders can identify OptiNose position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 94.2 M | |
| Common Stock Shares Outstanding | 112.1 M | |
| Total Stockholder Equity | -86.6 M | |
| Property Plant And Equipment Net | 815 K | |
| Cash And Short Term Investments | 73.7 M | |
| Cash | 73.7 M | |
| Accounts Payable | 3.9 M | |
| Net Debt | 56.5 M | |
| 50 Day M A | 0.6544 | |
| Total Current Liabilities | 176.5 M | |
| Other Operating Expenses | 93.7 M | |
| Non Current Assets Total | 2.4 M | |
| Non Currrent Assets Other | 1.6 M | |
| Stock Based Compensation | 5.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.553 | Quarterly Revenue Growth 0.031 | Return On Assets (0.10) | Return On Equity (10.51) |
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.